Comparison between Markolines Pavement Technologies Rights Issue 2023 and Shukra Pharmaceuticals Rights Issue 2023.
Rights Issue details
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Markolines Pavement Technologies Rights Issue 2023 and Shukra Pharmaceuticals Rights Issue 2023. Markolines Pavement Technologies Rights Issue 2023 is listed on BSE while Shukra Pharmaceuticals Rights Issue 2023 is listed on BSE.
Rights Issue Size and Price
The issue size of Markolines Pavement Technologies Rights Issue 2023 rights issue is ₹49.86 Crores, whereas Shukra Pharmaceuticals Rights Issue 2023 rights issue size is ₹18.79 Crores.
Rights Issue Timetable
Find all the important dates related to the rights issue. The record date of Markolines Pavement Technologies Rights Issue 2023 is Jan 17, 2023 while record date of Shukra Pharmaceuticals Rights Issue 2023 is Feb 02, 2023.
| | Markolines Pavement Technologies Limited | Shukra Pharmaceuticals Limited |
|---|
| Record Date | Jan 17, 2023 | Feb 02, 2023 |
| Credit of Rights Entitlements | Jan 25, 2023 | Feb 13, 2023 |
| Bid/Offer Opens On | Jan 27, 2023 | Feb 15, 2023 |
| Renunciation of Rights Entitlements | Feb 06, 2023 | Feb 23, 2023 |
| Bid/Offer Closes On | Feb 24, 2023 | Feb 28, 2023 |
| Deemed Date of Allotment | Feb 16, 2023 | Mar 08, 2023 |
| Credit Date | Feb 20, 2023 | Mar 14, 2023 |
| Listing Date | Feb 24, 2023 | Mar 15, 2023 |
Financials details
Comparison of Markolines Pavement Technologies Rights Issue 2023 and Shukra Pharmaceuticals Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| | Markolines Pavement Technologies Limited | Shukra Pharmaceuticals Limited |
|---|
| Financial | Markolines Pavement Technologies Limited Financial Information (Consolidated)| Period Ended | Total Revenue | Profit After Tax |
|---|
| 31-Mar-21 | 157.97 | 4.02 | | 31-Mar-22 | 186.9 | 10.11 | | Amount in ₹ Crore | | Shukra Pharmaceuticals Limited Financial Information (Consolidated)| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth |
|---|
| 31-Mar-21 | 35.61 | 11.55 | 0.19 | 15.60 | | 31-Mar-22 | 35.11 | 20.57 | 0.75 | 16.35 | | Amount in ₹ Crore | |
